SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations

NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) --

If you own shares in any of the companies listed above and

would like to discuss our investigations or have any questions concerning

this notice or your rights or interests, please contact:

Joshua Rubin, Esq.

WeissLaw LLP

1500 Broadway, 16^th Floor

New York, NY  10036

(212) 682-3025

(888) 593-4771

stockinfo@weisslawllp.com

Highlands Bankshares, Inc. HLND

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Highlands Bankshares, Inc. HLND in connection with the proposed acquisition of the Company by First Community Bankshares, Inc. FCBC.  Under the terms of the proposed acquisition, HLND shareholders will receive 0.273 shares of FCBC for each HLND share that they own.  If you own HLND shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/highlands-bankshares-inc/

Tennessee Community Bank Holdings, Inc. TNCB

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Tennessee Community Bank Holdings, Inc. TNCB in connection with the proposed acquisition of the Company Reliant Bancorp, Inc. ("RBNC") RBNC.  Under the terms of the proposed acquisition, TNCB shareholders will be entitled to receive $17.13 in cash and 0.769 shares of RBNC for each TNCB share that they hold.  If you own TNCB shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://weisslawllp.com/tennessee-community-bank-holdings-inc/

Achillion Pharmaceuticals, Inc. ACHN

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Achillion Pharmaceuticals, Inc. ACHN in connection with the proposed acquisition of the Company by Alexion Pharmaceuticals, Inc. ALXN.  Under the terms of the proposed acquisition, ACHN shareholders will receive $6.30 in cash for each ACHN share that they own.  If you own ACHN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/achillion-pharmaceuticals-inc/

Ra Pharmaceuticals, Inc. RARX

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Ra Pharmaceuticals, Inc. RARX in relation to the proposed acquisition of the Company by UCB S.A.  Under the terms of the acquisition agreement, RARX shareholders will receive $48.00 in cash for each RARX share that they own.  If you own RARX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/ra-pharmaceuticals-inc/